Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

CVS acquires the Albavet Group
shaking hands
Albavet is expected to benefit substantially from better purchasing power.
Acquisition a "major step forward" for vet group

Major veterinary group CVS has announced its acquisition of The Albavet Group, which employs more than 150 staff across three separate businesses.

The Albavet Group is comprised of a veterinary buying group trading under the name of Vetshare; instrumentation business VETisco and 11 small animal veterinary surgeries based in Fife, Glasgow, Nottingham, Stoke-on-Trent and Wallington.

Vetshare buying group has more than 400 members operating from over 500 surgeries across the UK. CVS chief executive Simon Innes said this acquisition offers a "major step forward" in its plan to develop a significant buying group.

CVS has also acquired the entire share capital of The Pet Crematorium, which consists of two crematoria, and VETisco, a small distribution business that currently makes a small loss.

Albavet is expected to benefit substantially from better purchasing power, while the geographical spread of its surgeries fit it well with CVS's existing sites.

Mr Innes commented: "The Albavet Group is a well-established, high quality operation. This acquisition significantly develops our surgeries in central Scotland and in the Midlands."

The most recent published accounts for Albavet show the group had a turnover of £6.6 million in the year up to 31 October 2014. The majority of this - £5.5 million - was generated by the surgeries.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.